Clinical trials
Joint Diseases trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 9 |
| Wroclaw University of Health and Sport Sciences | 2 |
| AO Innovation Translation Center | 1 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| Joanna Szczepańska-Gieracha | 1 |
| Lakefront Biotherapeutics NV | 1 |
| Levicept | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Joint Diseases | 28 |
| Arthritis | 16 |
| Arthritis, Rheumatoid | 13 |
| Musculoskeletal Diseases | 13 |
| Rheumatic Diseases | 6 |
| Autoimmune Diseases | 5 |
| Osteoarthritis | 5 |
| Arthritis, Psoriatic | 4 |
| Osteoarthritis, Knee | 4 |
| Connective Tissue Diseases | 3 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.